We next checked the stem cell markers ABCG2, BMI1, KLF4, MAD2, STAT3, CD44, MYC, NANOG2, and OCT4, the results of these experiments showed that ZNF471 could inhibit cell stemness in breast tumors. Here, CD44 is linked to breast neoplasm.